Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice

Ruben Vidal, Leticia Miravalle, Xiaoying Gao, Ana G. Barbeito, Martin A. Baraibar, Shahryar K. Hekmatyar, Mario Widel, Navin Bansal, Marie B. Delisle, Bernardino Ghetti

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Increased iron levels and iron-mediated oxidative stress play an important role in the pathogenesis of many neurodegenerative diseases. The finding that mutations in the ferritin light polypeptide (FTL) gene cause a neurodegenerative disease known as neuroferritinopathy or hereditary ferritinopathy (HF) provided a direct connection between abnormal brain iron storage and neurodegeneration. HF is characterized by a severe movement disorder and by the presence of nuclear and cytoplasmic ferritin inclusion bodies in glia and neurons throughout the CNS and in tissues of multiple organ systems. Here we report that the expression in transgenic mice of a human FTL cDNA carrying a thymidine and cytidine insertion at position 498 (FTL498-499InsTC) leads to the formation of nuclear and cytoplasmic ferritin inclusion bodies. As in HF, ferritin inclusions are seen in glia and neurons throughout the CNS as well as in cells of other organ systems. Our studies show histological, immunohistochemical, and biochemical similarities between ferritin inclusion bodies found in transgenic mice and in individuals with HF. Expression of the transgene in mice leads to a significant decrease in motor performance and a shorter life span, formation of ferritin inclusion bodies, misregulation of iron metabolism, accumulation of ubiquitinated proteins, and incorporation of elements of the proteasome into inclusions. This new transgenic mouse represents a relevant model of HF in which to study the pathways that lead to neurodegeneration in HF, to evaluate the role of iron mismanagement in neurodegenerative disorders, and to evaluate potential therapies for HF and related neurodegenerative diseases.

Original languageEnglish (US)
Pages (from-to)60-67
Number of pages8
JournalJournal of Neuroscience
Volume28
Issue number1
DOIs
StatePublished - Jan 2 2008

Fingerprint

Apoferritins
Iron Overload
Transgenic Mice
Inclusion Bodies
Ferritins
Iron
Neurodegenerative Diseases
Genes
Neuroglia
Ubiquitinated Proteins
Neurons
Cytidine
Neuroferritinopathy
Movement Disorders
Proteasome Endopeptidase Complex
Transgenes
Thymidine
Oxidative Stress
Complementary DNA
Light

Keywords

  • CNS
  • Ferritin
  • Hereditary ferritinopathy
  • Iron
  • Neurodegeneration
  • Nuclear inclusion

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. / Vidal, Ruben; Miravalle, Leticia; Gao, Xiaoying; Barbeito, Ana G.; Baraibar, Martin A.; Hekmatyar, Shahryar K.; Widel, Mario; Bansal, Navin; Delisle, Marie B.; Ghetti, Bernardino.

In: Journal of Neuroscience, Vol. 28, No. 1, 02.01.2008, p. 60-67.

Research output: Contribution to journalArticle

Vidal, Ruben ; Miravalle, Leticia ; Gao, Xiaoying ; Barbeito, Ana G. ; Baraibar, Martin A. ; Hekmatyar, Shahryar K. ; Widel, Mario ; Bansal, Navin ; Delisle, Marie B. ; Ghetti, Bernardino. / Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. In: Journal of Neuroscience. 2008 ; Vol. 28, No. 1. pp. 60-67.
@article{82b45db915984fa6a424ecc49487beeb,
title = "Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice",
abstract = "Increased iron levels and iron-mediated oxidative stress play an important role in the pathogenesis of many neurodegenerative diseases. The finding that mutations in the ferritin light polypeptide (FTL) gene cause a neurodegenerative disease known as neuroferritinopathy or hereditary ferritinopathy (HF) provided a direct connection between abnormal brain iron storage and neurodegeneration. HF is characterized by a severe movement disorder and by the presence of nuclear and cytoplasmic ferritin inclusion bodies in glia and neurons throughout the CNS and in tissues of multiple organ systems. Here we report that the expression in transgenic mice of a human FTL cDNA carrying a thymidine and cytidine insertion at position 498 (FTL498-499InsTC) leads to the formation of nuclear and cytoplasmic ferritin inclusion bodies. As in HF, ferritin inclusions are seen in glia and neurons throughout the CNS as well as in cells of other organ systems. Our studies show histological, immunohistochemical, and biochemical similarities between ferritin inclusion bodies found in transgenic mice and in individuals with HF. Expression of the transgene in mice leads to a significant decrease in motor performance and a shorter life span, formation of ferritin inclusion bodies, misregulation of iron metabolism, accumulation of ubiquitinated proteins, and incorporation of elements of the proteasome into inclusions. This new transgenic mouse represents a relevant model of HF in which to study the pathways that lead to neurodegeneration in HF, to evaluate the role of iron mismanagement in neurodegenerative disorders, and to evaluate potential therapies for HF and related neurodegenerative diseases.",
keywords = "CNS, Ferritin, Hereditary ferritinopathy, Iron, Neurodegeneration, Nuclear inclusion",
author = "Ruben Vidal and Leticia Miravalle and Xiaoying Gao and Barbeito, {Ana G.} and Baraibar, {Martin A.} and Hekmatyar, {Shahryar K.} and Mario Widel and Navin Bansal and Delisle, {Marie B.} and Bernardino Ghetti",
year = "2008",
month = "1",
day = "2",
doi = "10.1523/JNEUROSCI.3962-07.2008",
language = "English (US)",
volume = "28",
pages = "60--67",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "1",

}

TY - JOUR

T1 - Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice

AU - Vidal, Ruben

AU - Miravalle, Leticia

AU - Gao, Xiaoying

AU - Barbeito, Ana G.

AU - Baraibar, Martin A.

AU - Hekmatyar, Shahryar K.

AU - Widel, Mario

AU - Bansal, Navin

AU - Delisle, Marie B.

AU - Ghetti, Bernardino

PY - 2008/1/2

Y1 - 2008/1/2

N2 - Increased iron levels and iron-mediated oxidative stress play an important role in the pathogenesis of many neurodegenerative diseases. The finding that mutations in the ferritin light polypeptide (FTL) gene cause a neurodegenerative disease known as neuroferritinopathy or hereditary ferritinopathy (HF) provided a direct connection between abnormal brain iron storage and neurodegeneration. HF is characterized by a severe movement disorder and by the presence of nuclear and cytoplasmic ferritin inclusion bodies in glia and neurons throughout the CNS and in tissues of multiple organ systems. Here we report that the expression in transgenic mice of a human FTL cDNA carrying a thymidine and cytidine insertion at position 498 (FTL498-499InsTC) leads to the formation of nuclear and cytoplasmic ferritin inclusion bodies. As in HF, ferritin inclusions are seen in glia and neurons throughout the CNS as well as in cells of other organ systems. Our studies show histological, immunohistochemical, and biochemical similarities between ferritin inclusion bodies found in transgenic mice and in individuals with HF. Expression of the transgene in mice leads to a significant decrease in motor performance and a shorter life span, formation of ferritin inclusion bodies, misregulation of iron metabolism, accumulation of ubiquitinated proteins, and incorporation of elements of the proteasome into inclusions. This new transgenic mouse represents a relevant model of HF in which to study the pathways that lead to neurodegeneration in HF, to evaluate the role of iron mismanagement in neurodegenerative disorders, and to evaluate potential therapies for HF and related neurodegenerative diseases.

AB - Increased iron levels and iron-mediated oxidative stress play an important role in the pathogenesis of many neurodegenerative diseases. The finding that mutations in the ferritin light polypeptide (FTL) gene cause a neurodegenerative disease known as neuroferritinopathy or hereditary ferritinopathy (HF) provided a direct connection between abnormal brain iron storage and neurodegeneration. HF is characterized by a severe movement disorder and by the presence of nuclear and cytoplasmic ferritin inclusion bodies in glia and neurons throughout the CNS and in tissues of multiple organ systems. Here we report that the expression in transgenic mice of a human FTL cDNA carrying a thymidine and cytidine insertion at position 498 (FTL498-499InsTC) leads to the formation of nuclear and cytoplasmic ferritin inclusion bodies. As in HF, ferritin inclusions are seen in glia and neurons throughout the CNS as well as in cells of other organ systems. Our studies show histological, immunohistochemical, and biochemical similarities between ferritin inclusion bodies found in transgenic mice and in individuals with HF. Expression of the transgene in mice leads to a significant decrease in motor performance and a shorter life span, formation of ferritin inclusion bodies, misregulation of iron metabolism, accumulation of ubiquitinated proteins, and incorporation of elements of the proteasome into inclusions. This new transgenic mouse represents a relevant model of HF in which to study the pathways that lead to neurodegeneration in HF, to evaluate the role of iron mismanagement in neurodegenerative disorders, and to evaluate potential therapies for HF and related neurodegenerative diseases.

KW - CNS

KW - Ferritin

KW - Hereditary ferritinopathy

KW - Iron

KW - Neurodegeneration

KW - Nuclear inclusion

UR - http://www.scopus.com/inward/record.url?scp=38149140232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149140232&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3962-07.2008

DO - 10.1523/JNEUROSCI.3962-07.2008

M3 - Article

C2 - 18171923

AN - SCOPUS:38149140232

VL - 28

SP - 60

EP - 67

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 1

ER -